Reaktion #66471

ord-887a225e64254081b05b5c67b8cbd9d4

Reaktionsgleichung

Cc1cc(NC23N=CN=C2C=NC(Cl)=N3)n[nH]1
(2-chloro-purin-4-yl)-(5-methyl-1H-pyrazol-3-yl)-amine
CC1CCNCC1
4-methylpiperidine
O=C([O-])[O-].[K+].[K+]
Potassium carbonate
Cc1cc(NC23N=CN=C2C=NC(N2CCC(C)CC2)=N3)[nH]n1
solid
Ausbeute 90.0%
Cc1cc(NC23N=CN=C2C=NC(N2CCC(C)CC2)=N3)[nH]n1
[2-(4-Methylpiperidin-1-yl)-purin-4-yl]-(5-methyl-2H-pyrazol-3-yl)-amine
Ausbeute 90.0%

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Temperaturthe reaction mixture heated
  2. 2
    Temperaturat reflux overnight
  3. 3
    SonstigeThe solvent was evaporated
  4. 4
    workup.DISSOLUTIONthe residue dissolved in a mixture EtOH:water (1:3, 4 mL)
  5. 5
    FiltrationThe resulting suspension was filtered
  6. 6
    Waschenwashed with water (×2)
  7. 7
    Waschenrinsed with Et2O (×2)

Vorschrift

To a solution of (2-chloro-purin-4-yl)-(5-methyl-1H-pyrazol-3-yl)-amine (200 mg, 0.80 mmol) was added 4-methylpiperidine (4 mL, 8.01 mmol) and the reaction mixture heated at reflux overnight. The solvent was evaporated and the residue dissolved in a mixture EtOH:water (1:3, 4 mL). Potassium carbonate (57 mg, 0.41 mmol) was added and the mixture was stirred at room temperature for 2 hours. The resulting suspension was filtered, washed with water (×2) and rinsed with Et2O (×2) to afford IV-33 as a white solid (225 mg, 90%): mp>300° C.; 1H NMR (DMSO) δ 0.91 (3H, d), 1.10 (2H, m), 1.65 (3H, m), 2.24 (3H, s), 2.84 (2H, m), 4.60 (2H, m), 6.40 (1H, s), 7.87 (1H, m), 9.37-9.59 (1H, m), 12.03-12.39 (2H, m); IR (solid) 1651, 1612, 1574, 1484, 1446, 1327, 1317, 1255, 1203; MS 313.3 (M+H)+.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08524720B2uspto-grants-2013_09